世界*實(shí)驗(yàn)材料供應(yīng)商 Glycotope正式授權(quán)上海起發(fā)為其中國(guó)代理, Glycotope在一直是行業(yè)的*,一直為廣大科研客戶提供zui為的產(chǎn)品和服務(wù),上海起發(fā)一直秉承為中國(guó)科研客戶帶來(lái)的產(chǎn)品,的服務(wù),簽約 Glycotope就是為了給廣大科研客戶帶來(lái)更加完善的產(chǎn)品和服務(wù),您的滿意將是我們zui大的收獲
Glycotope中國(guó)代理, Glycotope上海代理, Glycotope北京代理,Glycotope廣東代理, Glycotope江蘇代理Glycotope湖北代理,Glycotope天津,Glycotope黑龍江代理,Glycotope內(nèi)蒙古代理,Glycotope吉林代理,Glycotope福建代理, Glycotope江蘇代理, Glycotope浙江代理, Glycotope四川代理,
GLYCOTOPE是前Nemod Biotherapeutics 安全官及Max-Delbrueck中心分子醫(yī)藥研究團(tuán)隊(duì)學(xué)術(shù)帶頭人 Dr. Steffen Goletz,以及Eckert & Ziegler Strahlen- und Medizintechnik AG的CEO及創(chuàng)建人Dr. Andreas Eckert于2001年創(chuàng)立。公司創(chuàng)立之初僅有員工8人,主要開(kāi)發(fā)了GlycoExpress™糖基化純化技術(shù)。目前,GLYCOTOPE已經(jīng)擁有員工超過(guò)160人,在柏林及海德堡均設(shè)有公司,基于zui初的GlycoExpress™糖基化純化技術(shù),GLYCOTOPE已成長(zhǎng)為第二代生物治療企業(yè)。除糖基化研究之外,GLYCOTOPE公司于2008年收購(gòu)Orpegen Pharma的生物技術(shù)部,成立了GLYCOTOPE生物技術(shù)公司,該公司擁有GMP生產(chǎn)條件,使得GLYCOTOPE公司的所有產(chǎn)品均可實(shí)現(xiàn)GMP生產(chǎn)。
作為糖生物學(xué)研究領(lǐng)域的,GLYCOTOPE致力于研發(fā)創(chuàng)新性的生物制藥技術(shù)用以優(yōu)化人類糖基化結(jié)構(gòu)修飾、分析以及開(kāi)發(fā)高度特異的抗腫瘤細(xì)胞表面糖分子抗體?;?/span>GlycoExpress以及GlycoBody技術(shù), Glycotope擁有一個(gè)可全面研究、生產(chǎn)糖蛋白的研究平臺(tái),可提供多種純化糖蛋白以及高特異性的抗糖蛋白抗體。
Glycotope的主要產(chǎn)品:
一、臨床糖基化抗體:
Glycotope公司目前在已處于臨床試驗(yàn)的糖基化抗體主要包括:
(1)PankoMab-GEX (GT-MAB 2.5-GEX™):已處于二期臨床(Ovarian Cancer,2013)的腫瘤治療糖基化抗體。
(2)新型EGFR抗體 CetuGEX (GT-MAB 5.2-GEX™), 已處于二期臨床(Head&Neck Cancer,2013) (3)TrasGEX (GT-MAB 7.3-GEX™) :HER2抗體,已完成一期臨床試驗(yàn)。
(4)FSH-GEX (GT-GP 2.4-GEX™):糖基化修飾的Follicle-Stimulating Hormone,是Glycotope’s*臨床治療的非抗體產(chǎn)品,已于2014年進(jìn)入三期臨床試驗(yàn)。
二、免疫診斷試劑:
Glycotope生物技術(shù)公司的診斷試劑盒產(chǎn)品集中于細(xì)胞功能的定量評(píng)估領(lǐng)域,其免疫功能檢測(cè)試劑盒基于流式細(xì)胞術(shù)可以快速的檢測(cè)細(xì)胞在免疫反應(yīng)下的各種功能特性,其方便快速的檢測(cè)試劑系統(tǒng)使其適用于臨床檢測(cè)。
三、科研服務(wù):
基于*的科研平臺(tái)及訓(xùn)練有素的員工,Glycotope除了上述有形試劑外還提供多種形式的科研服務(wù),包括試驗(yàn)研究設(shè)計(jì)、實(shí)施及分析等流程。
PHAGOBURST™
貨號(hào):10-0200
規(guī)格:100 analyses
Clinical Diagnostic for the Quantitative Analysis of Leukocyte Oxidative Burst in whole blood
臨床診斷人體全血白細(xì)胞氧化破裂的定量檢測(cè)
· Functional test ex vivo 來(lái)自體內(nèi)的功能測(cè)試 · Evaluation of single cells to detect heterogenous populations 評(píng)價(jià)檢測(cè)單個(gè)細(xì)胞異質(zhì)種群 · Whole blood assay: No isolation procedures and optimal culture medium 全血檢測(cè):沒(méi)有隔離程序和*培養(yǎng)基 · Physiological stimulans for phagocytes: Bacteria and fMLP 吞噬細(xì)胞生理興奮勁:細(xì)菌和fMLP · Dose response: Low and high stimulant 沒(méi)有靜電工件比較乳膠珠子聚苯乙烯管內(nèi) · Standardized test procedure 標(biāo)準(zhǔn)化測(cè)試程序 · Exclusion of aggregation artifacts by DNA staining 通過(guò)DNA染色排除聚合工件 · Compatible with whole blood of mice and rats 兼容的小鼠和大鼠全血 · Fast assay: Whole assay time is 1.5 hours 快速測(cè)定:整個(gè)試驗(yàn)時(shí)間是1.5小時(shí) 100 analyses. Clinical Diagnostic for the Quantitative Analysis of Leukocyte Oxidative Burst in Human Whole Blood. Evaluation by flow cytometry. 100次分析。臨床診斷人體全血白細(xì)胞氧化破裂的定量檢測(cè)。通過(guò)流式細(xì)胞術(shù)進(jìn)行評(píng)估。 Clinical Diagnostic for the Quantitative Analysis of Leukocyte Oxidative Burst in Human Whole Bloods SUMMARY and EXPLANATION BURSTTEST (PHAGOBURST) allows the quantitative determination of leukocyte oxidative burst in heparinized whole blood. It contains unlabeled opsonized bacteria (E.coli), phorbol 12-myristate 13-acetate (PMA) and the chemotactic peptide N-formyl-Met-Leu-Phe (fMLP) as stimulants, Dihydrorhodamine (DHR) 123 as a fluorogenic substrate and necessary reagents. It determines the percentage of phagocytic cells which produce reactive oxidants (conversion of DHR 123 to R 123) and their enzymatic activity (amount of R 123 per cell). The evaluation of these bioactivities should be performed by flow cytometry. BURSTTEST(PHAGOBURST)允許定量測(cè)定白細(xì)胞氧化闖入肝素化全血。 它包含未標(biāo)記的促進(jìn)調(diào)理作用的細(xì)菌(大腸桿菌),佛波醇12十四烷酸乙酸13(PMA)和趨化作用的多肽n甲酰遇見(jiàn)亮氨酸板式換熱器(fMLP),二氫若丹明(DHR)123作為一個(gè)熒光襯底和必要的試劑。它決定了吞噬細(xì)胞產(chǎn)生活性氧化劑的比例(轉(zhuǎn)換DHR 123 到 R 1233)及其酶活性(每個(gè)細(xì)胞R 123的數(shù)量)。 這些生物活性的測(cè)定應(yīng)該有流式細(xì)胞術(shù)完成。 APPLICATIONS The diagnostic kit is intended to investigate the altered oxidative burst activity found in various disorders and to evaluate the effects of drugs. Reduced or missing burst activity is observed in inborne defects like the chronic granulomatous disease (CGD). CGD is a heterogenous group of inherited disorders that usually manifests itself during the first two years of life (3, 4). The disease is characterized clinically by repeated and life-threatening infections caused by bacterial and fungal organisms. These infections typically consist of pneumonia, lymphadenitis, or abscesses that involve lymph nodes, lungs, and liver. The NADPH oxidase is the enzyme system responsible for producing superoxide anion, which is quickly converted to hydrogen peroxide and hydroxyl radicals. Abnormalities in the constituent peptides of the NADPH oxidase enzyme system lead to the dysfunctions characteristic of CGD. Neutrophils from CGD patients fail to produce a significant oxidative burst following stimulation. Different forms of CGD are described (classical X-linked CGD and autosomal recessive patterns). BURSTTEST (PHAGOBURST?) is a rapid and sensitive method for the diagnosis of CGD and for the detection of X-linked carriers. The oxidative burst of granulocytes is impaired in transplant patients and patients with AIDS (6). The spontaneous and fMLP-induced neutrophil respiratory burst was shown to be increased in neonates with laboratory signs of infection (7). Various immunomodulators (e.g., cytokines (GM-CSF, G-CSF, TNF) or drugs) seem to have effects on the oxidative burst. By using fMLP as a low stimulant one can investigate additive or priming effects (8) of test substances. The diagnostic kit is also applicable on blood of mice, rats, rabbits, dogs, cattle and other species. 診斷測(cè)試組旨在研究改變了的氧化破裂活動(dòng)中發(fā)現(xiàn)各種障礙和評(píng)估藥物的影響。 觀察細(xì)胞的減少或缺失的破裂活動(dòng)像慢性肉芽腫性疾病(CGD) 慢性肉芽腫性疾病是一個(gè)異構(gòu)群遺傳疾病,通常體現(xiàn)在生命的zui初兩年期間(3、4)。這種疾病的臨床特征是由于細(xì)菌和真菌重復(fù)和危機(jī)生命的感染。這些感染通常包括肺炎、淋巴腺炎或膿腫涉及到淋巴結(jié)、肺和肝。NADPH氧化酶的酶系統(tǒng)是負(fù)責(zé)生產(chǎn)超氧化物陰離子,迅速轉(zhuǎn)化為過(guò)氧化氫和羥基自由基。NADPH氧化酶系統(tǒng)在組成多肽中的畸形導(dǎo)致慢性肉芽腫性疾病功能障礙性特點(diǎn)。CGD患者的中性粒細(xì)胞刺激后無(wú)法產(chǎn)生顯著的氧化破裂。BURSTTEST (PHAGOBURST?)是一種快速有效診斷慢性肉芽腫性疾病和檢測(cè)X連鎖隱性遺傳疾病攜帶者的方法。 氧化破裂的粒細(xì)胞在需要移植的病人和艾滋病患者中受損。無(wú)意識(shí)和誘發(fā)性fMLP嗜中性粒細(xì)胞破裂被證明會(huì)增加新生兒實(shí)驗(yàn)室感染的跡象。各種免疫調(diào)節(jié)劑(如細(xì)胞激素(GM-CSF, G-CSF, TNF)或藥品)似乎會(huì)對(duì)氧化破裂產(chǎn)生影響。通過(guò)使用fMLP可以研究添加劑或激發(fā)效應(yīng)(8)的測(cè)試物質(zhì)。 診斷試劑盒也適用于小老鼠、大老鼠、兔子、狗、牛和其他物種的血液。
BURSTTEST (PHAGOBURST?) allows the quantitative determination of leukocyte oxidative burst. The BURSTEST kit contains unlabelled opsonized E.coli bacteria as particulate stimulus, the protein kinase C ligand phorbol 12-myristate 13-acetate (PMA) as high stimulus and the chemotactic peptide N-formyl-MetLeuPhe (fMLP) as low physiological stimulus, Dihydrorhodamine (DHR) 123 as a fluorogenic substrate (5) and necessary reagents. Heparinized whole blood is incubated with the various stimuli at 37°C, a sample without stimulus serves as negative background control. Upon stimulation, granulocytes and monocytes produce reactive oxygen metabolites (superoxide anion, hydrogen peroxide, hypochlorous acid) which destroy bacteria inside the phagosome. Formation of the reactive oxidants during the oxidative burst can be monitored by the addition and oxidation of DHR 123. The reaction is stopped by addition of LYSING SOLUTION, which removes erythrocytes and results in a partial fixation of leukocytes. After one washing step with WASHING SOLUTION, DNA STAINING SOLUTION is added to exclude aggregation artifacts of bacteria or cells. The percentage of cells having produced reactive oxygen radicals are then analyzed as well as their mean fluorescence intensity (enzymatic activity). |
溫馨提示:不可用于臨床治療。 |
我們公司zui大優(yōu)勢(shì)是強(qiáng)大的采購(gòu),
1:基本什么都能進(jìn)口,血清,抗體,耗材,還有部分限制進(jìn)口的,
2:貨品全,現(xiàn)經(jīng)營(yíng)過(guò)700多個(gè)品牌,基本所有生物試劑耗材都可以進(jìn)口,特別是冷偏的產(chǎn)品那就更有優(yōu)勢(shì),
3:提供加急服務(wù),一般1-2周到貨,超過(guò)時(shí)限加急費(fèi)全免
4:價(jià)格公道,絕大部分價(jià)格有優(yōu)勢(shì),當(dāng)然不能保證100%產(chǎn)品都是,因?yàn)橐馕吨鴽](méi)有服務(wù).
5:良好的信譽(yù),大部分客戶我們提供貨到付款服務(wù),客戶包括清華,北大 交大 復(fù)旦,中山等100多所大學(xué),ROCHE,阿斯利康,國(guó)藥 ,fisher等500多家公司
6:我們*代理的品牌有:Antibody Research Corporation,arcticzymes,Biorelevant,AmberGen, Inc. ,clemente-associates,clodronaiposomes,Columbia Biosciences,enzyme research,Gene Bridges GmbH,Genovis,AmberGen, Inc. Biotechnology GmbH,Haematologic Technologies HTI Haemtech,hookelabs,Immudex,Innovative Research of America,inspiralis ,List Biological Laboratories, Inc.,lumafluor,Microsurfaces,multiplicom,nanotools,Pel-Freez Biologicals,pentapharm,progen,Protein Ark,QA-Bio,Inc,QA-Bio,IncQuickZyme Biosciences,Teknova,TriLink BioTechnologies, Inc.,Zyagen Laboratories 等
7:我們還是invitrogen,qiagen,Midland BioProducts Corporationam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等知名*批發(fā),歡迎合作。
電話
QQ咨詢
4006551678